Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses

被引:41
作者
Gulati, U
Wu, WX
Gulati, S
Kumari, K
Waner, JL
Air, GM
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
[2] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA
关键词
human influenza virus; specificities; elution; sialidasc; glycophorin; alpha 2,6 sialic acid; alpha 2,8 sialic acid; hemagglutinin; neuraminidase activity;
D O I
10.1016/j.virol.2005.05.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The hemagglutinin (HA) of influenza viruses initiates infection by binding to sialic acid on the cell surface via alpha 2,6 (human) or alpha 2,3 (avian) linkage. The influenza neuraminidase (NA) can cleave both alpha 2,3- and alpha 2,6-linked sialic acids, but all influenza NAs have a marked preference for the non-human alpha 2,3 linkage. Recent H3N2 influenza viruses have lost the ability to agglutinate chicken red blood cells. To determine if changes in HA specificity or affinity correlate with NA specificity or activity, we examined red cell binding and elution of a series of H3N2 viruses. We found that the NA activity of many influenza viruses does not release binding by their HA. In some egg-adapted strains, lack of elution correlates with low levels of viral NA activity, and these elute rapidly when bacterial NA is added. However, a Fujian-like virus, A/Oklahoma/323/03, does not elute by its own NA or with Vibrio cholerae sialidase, and it binds to red cells pre-treated with V cholerae sialidase. It elutes after addition of the broad specificity Micromonospora viridifaciens sialidase. Human glycophorin inhibits A/Oklahoma/323/03 hemagglutination 6-fold better than fetuin. We conclude that specific forms of sialic acid are used as receptor by recent human H3N2 influenza viruses, perhaps involving branched a2,6 sialic acid or alpha 2,8 sialic acid structures on O-linked carbohydrates. The virus itself has no O-linked glycans, so even though the NA is not able to cleave receptors on cells, the viruses will not self-aggregate. It will be important to monitor efficacy of neuraminidase inhibitors in case there are NA-resistant receptors in the human respiratory tract that allow the viruses to be less dependent on NA activity. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 59 条
[1]   Influenza neuraminidase as target for antivirals [J].
Air, GM ;
Ghate, AA ;
Stray, SJ .
ADVANCES IN VIRUS RESEARCH, VOL 54, 1999, 54 :375-+
[2]   RED-CELLS BOUND TO INFLUENZA-VIRUS N9 NEURAMINIDASE ARE NOT RELEASED BY THE N9 NEURAMINIDASE ACTIVITY [J].
AIR, GM ;
LAVER, WG .
VIROLOGY, 1995, 211 (01) :278-284
[3]   PURIFICATION, CRYSTALLIZATION, AND CHARACTERIZATION OF NEURAMINIDASE FROM MICROMONOSPORA-VIRIDIFACIENS [J].
AISAKA, K ;
IGARASHI, A ;
UWAJIMA, T .
AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1991, 55 (04) :997-1004
[4]   Cloning, characterization, and phylogenetic analysis of Siglec-9, a new member of the CD33-related group of Siglecs - evidence for co-evolution with sialic acid synthesis pathways [J].
Angata, T ;
Varki, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :22127-22135
[5]  
AYMARDHENRY M, 1973, B WORLD HEALTH ORGAN, V48, P199
[6]   Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140 [J].
Bantia, S ;
Ghate, AA ;
Ananth, SL ;
Babu, YS ;
Air, GM ;
Walsh, GM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :801-807
[7]  
BARTON NW, 1973, J BIOL CHEM, V248, P7353
[8]  
BAUM LG, 1990, ACTA HISTOCHEM, P35
[9]   THE N2 NEURAMINIDASE OF HUMAN INFLUENZA-VIRUS HAS ACQUIRED A SUBSTRATE-SPECIFICITY COMPLEMENTARY TO THE HEMAGGLUTININ RECEPTOR SPECIFICITY [J].
BAUM, LG ;
PAULSON, JC .
VIROLOGY, 1991, 180 (01) :10-15
[10]   SEPARATION OF THE COMPLEX ASPARAGINE-LINKED OLIGOSACCHARIDES OF THE GLYCOPROTEIN FETUIN AND ELUCIDATION OF 3 TRIANTENNARY STRUCTURES HAVING SIALIC ACIDS LINKED ONLY TO GALACTOSE RESIDUES [J].
BENDIAK, B ;
HARRISBRANDTS, M ;
MICHNICK, SW ;
CARVER, JP ;
CUMMING, DA .
BIOCHEMISTRY, 1989, 28 (15) :6491-6499